Biomeme signs deal to double space, relocate Center City Headquarters

Biomeme Inc., a diagnostic startup behind a rapid Covid-19 test, has signed a lease on 44,000 square feet to relocate its headquarters, lab and production space to 401 N. Broad St. in Center City.

The company is currently housed in about 20,000 square feet at 1015 Chestnut St. and has grown during the pandemic as a result of its Covid test, which also detects variants that have been transmitted around the world.

The company, which previously invented a medical device called a PCR thermocycler that allows users to analyze DNA from an iPhone, received a $3 million grant from Pennsylvania’s Redevelopment Assistance Capital Program to help fund the build-out of its new headquarters at 401 N. Broad, where it signed a 10-year lease.

Biomeme will join Nerd Street Gamers, another new tenant to the building. Last year, Nerd Street leased 35,000 square feet at 401 N. Broad and will relocate its headquarters to the 11-story, 1.3-million-square-foot building.

To read more about Biomede’s relocations click below for the full article.
Read the full article


More News and Highlights